RA
ZSAN

Royce & Associates’s Zosano Pharma Corporation ZSAN Stock Holding History

Royce & Associates’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-129
Closed -$910K – 1257
2015
Q1 		$910K Buy
+129
New +$968K ﹤0.01% 1030

Other funds holding ZSAN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
VAM
Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return